News for 'National Institute for Health Research'

Blame game at this juncture is suicidal

Blame game at this juncture is suicidal

Rediff.com12 May 2021

To build one's political and ideological arguments on the dead bodies piling up outside our crematoriums is despicable and breaches the basic tenet of human civility, argues Vivek Gumaste.

Omicron: 200 Million Indians Yet To Be Vaccinated

Omicron: 200 Million Indians Yet To Be Vaccinated

Rediff.com24 Dec 2021

We need to give a booster shot to all our frontline workers first as if they fall victim to Omicron, the health system will collapse, points out Ramesh Menon.

Life is tough for India's gig workers

Life is tough for India's gig workers

Rediff.com13 Feb 2022

The recent protests by employees of Urban Company and the case of a a Zomato delivery executive who died in a road accident point to the severely straitened condition of gig workers during the ongoing Covid-19 pandemic. Budget 2021 had promised several measures to help the cause of gig economy workers, but most of them are yet to see the light of day. Even after a year, the country's gig workers continue to be without any social security cover or a minimum wage guarantee. "In Budget 2021, finance minister Nirmala Sitharaman had announced that the government is looking toward including migrant and gig workers for social security benefits," says Srinivas Kotni, managing partner, Lexport, a consulting firm. Parliament had passed the Code on Wages in 2019 and Code on Industrial Relations, Social Security and Occupational Safety, Health and Working Conditions in 2020.

Enough stockpile of COVID-19 vaccine for priority groups: Niti member

Enough stockpile of COVID-19 vaccine for priority groups: Niti member

Rediff.com4 Jan 2021

Paul noted that "three to four months from now, there will be other vaccines and the stockpile will be even bigger. "And more acceleration can be brought about in the vaccination programme," Paul added.

India's children may get 2 Covid vaccines by December

India's children may get 2 Covid vaccines by December

Rediff.com28 Jun 2021

While Bharat Biotech's Covaxin is in trials among children already, Serum Institute of India will begin Novavax vaccine trials on children from July, whereas the Pfizer vaccine has been approved for adolescents in the United States; and Cadila Healthcare's ZyCoV-D has done trials on 12 year-olds and above already, reports Sohini Das.

Russian fund to supply Dr Reddy's with 10cr doses of Covid vaccine

Russian fund to supply Dr Reddy's with 10cr doses of Covid vaccine

Rediff.com16 Sep 2020

The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India, RDIF and Dr Reddy's said in a joint statement.

Chandrayaan-3 to be launched in first half of 2021

Chandrayaan-3 to be launched in first half of 2021

Rediff.com5 Mar 2020

Chandrayaan-II hard-landed on lunar surface last year. The Indian Space Research Organisation had then resolved to launch the project again. It had said the project is likely to be launched by the end of the year.

Govt exploring possibility to produce Covaxin abroad

Govt exploring possibility to produce Covaxin abroad

Rediff.com21 May 2021

To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said.

Is Baba Ramdev's Sanjivini Booti for real?

Is Baba Ramdev's Sanjivini Booti for real?

Rediff.com5 Oct 2008

Uttarakhand health department officials are trying to verify claims of Yoga guru Baba Ramdev of having found the 'Sanjivini Booti', mentioned in the Ramayana.

Lockdown, containment measures successful: ICMR sero-survey

Lockdown, containment measures successful: ICMR sero-survey

Rediff.com12 Jun 2020

The first part of the study conducted by the Indian Council of Medical Research (ICMR) revealed that 0.73 per cent of the population surveyed showed evidence of past exposure to SARS-CoV-2, and that urban slum population was the most vulnerable to the infection, ICMR Director General Balram Bhargava said at a press conference.

Banks' NPAs never went away, they were only hidden

Banks' NPAs never went away, they were only hidden

Rediff.com26 May 2022

Indeed, there were frauds, and the politician-banker-industrialist nexus played a role in the rise of NPAs, but governance issues in Indian banking are far more nuanced and complex, reveals Tamal Bandyopadhyay.

At current pace India will inoculate 75% of population only by mid-2024

At current pace India will inoculate 75% of population only by mid-2024

Rediff.com2 Jun 2021

The average rate of COVID-19 vaccination in the country has been 10.8 million per week. At that rate, it will take India till December 2024 to complete two billion doses.

India records over 1.34 lakh Covid cases, 2,887 deaths

India records over 1.34 lakh Covid cases, 2,887 deaths

Rediff.com3 Jun 2021

The number of active cases has reduced to 17,13,413, accounting for 6.02 per cent of the total number of cases.

Is Ireland a good place to study?

Is Ireland a good place to study?

Rediff.com17 Jan 2019

Post Brexit, Irish universities are seeing a surge in applications says Barry O'Driscoll, senior spokesperson for Education in Ireland.

India working on Russia's proposal to manufacture Covid vaccine

India working on Russia's proposal to manufacture Covid vaccine

Rediff.com8 Sep 2020

Dr V K Paul, Member (Health) Niti Aayog, who also chairs the national expert group on COVID-19 vaccine administration, said the government attaches 'great importance to this offer of partnership from a very special friend to this nation'.

How reliable is India's data on COVID-19 deaths?

How reliable is India's data on COVID-19 deaths?

Rediff.com31 May 2020

It is necessary to have a dramatic increase in the number of rapid tests for COVID-19 conducted on a large number of people and that should become the basis for estimating the morbidity and mortality due to COVID-19, not relying only on hospital reports, says Professor K Srinivasan.

Govt fast-tracks approval for foreign-produced COVID vaccines

Govt fast-tracks approval for foreign-produced COVID vaccines

Rediff.com13 Apr 2021

The first 100 beneficiaries of such foreign vaccines shall be assessed for seven days for safety outcomes before it is rolled out for further immunisation programme within the country, the Union health ministry said.

'Degree not sole proof of education'

'Degree not sole proof of education'

Rediff.com30 Dec 2020

'A mother, a farmer and cattle owner, all have valuable knowledge, but academia has failed to acknowledge their wisdom.'

COVID-19 crisis far from over, say scientists

COVID-19 crisis far from over, say scientists

Rediff.com24 Sep 2020

The expert noted that in India the pandemic is unlikely to be over in the months to come, and the number of people getting infected will continue to rise.

'Detect every probable COVID-19 case'

'Detect every probable COVID-19 case'

Rediff.com26 Apr 2020

'If done well, the containment measures can help minimise the impact of the epidemic.'

'No preparedness planning, no accountability, no action plan'

'No preparedness planning, no accountability, no action plan'

Rediff.com8 May 2021

'This government did not have any plan for safety stocks of essential medicines.'

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Rediff.com30 Sep 2021

In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.

Sept accounted for over 41% of total COVID-19 cases in India

Sept accounted for over 41% of total COVID-19 cases in India

Rediff.com1 Oct 2020

September witnessed 24,33,319 people recuperating from coronavirus infection contributing to around 46.15 per cent of the total 52,73,201 recoveries registered so far in the country.

Harvard, MIT sue Trump administration over student visa row

Harvard, MIT sue Trump administration over student visa row

Rediff.com9 Jul 2020

The Trump administration announced those F-1 and M-1 (non-academic and vocational students) visa holders planning to take online classes only will not be allowed to remain in the United State.

What economists and FM Sitharaman discussed in pre-Budget meet

What economists and FM Sitharaman discussed in pre-Budget meet

Rediff.com17 Jun 2019

Concerned by GDP slowdown and unrealistic tax targets, the economists urged Finance Minister Nirmala Sitharaman to implement long-term structural steps like land and labour reforms. Warning against any off-Budget financing the economists said the government should prepare a statement of intent for its social, rural and welfare sector expenditure.

Premature to declare Covid third wave: Scientists

Premature to declare Covid third wave: Scientists

Rediff.com4 Aug 2021

The rise in fresh Covid cases and the effective reproduction number -- indication of how fast an infection spreads -- in many states is worrying but don't panic. Instead, mask up and get vaccinated, say experts, stressing that it is too early to declare the beginning of a new wave.

'India may see second wave of COVID-19 in monsoon'

'India may see second wave of COVID-19 in monsoon'

Rediff.com24 Apr 2020

Recent studies in China and Europe observed that the infection might relapse in those people who have already recovered from earlier phases.

Experts welcome WHO's decision to resume HCQ clinical trial

Experts welcome WHO's decision to resume HCQ clinical trial

Rediff.com4 Jun 2020

The global heath body had earlier suspended the hydroxychloroquine arm of the clinical trials of experimental COVID-19 drugs over safety concerns.

China listening, Jaishankar brings up territorial integrity at BRICS online meet

China listening, Jaishankar brings up territorial integrity at BRICS online meet

Rediff.com1 Jun 2021

The five-nation grouping BRICS on Tuesday resolved to combat terrorism in all its forms and manifestations, including the cross-border movement of terrorists, and vowed to step up joint efforts in building support for an India-backed global framework to effectively deal with the menace.

Vaccination for COVID-19 will be voluntary: Govt

Vaccination for COVID-19 will be voluntary: Govt

Rediff.com18 Dec 2020

The ministry further stated that it was advisable to receive a complete schedule of the anti-coronavirus vaccine irrespective of past history of infection with COVID-19 as this will help in developing a strong immune response against the disease.

COVID-19 doubling rate 11 days, fatality 3.2%: Govt

COVID-19 doubling rate 11 days, fatality 3.2%: Govt

Rediff.com30 Apr 2020

Also, the recovery rate in COVID-19 patients has progressively improved from 13.06 per cent to over 25 per cent in the country over the last 14 days. Addressing a press briefing, Joint Secretary in the ministry Lav Agarwal said the doubling rate of COVID-19 cases in several states is better than the national average.

Budget 2018: What young India needs from Modi Sarkar

Budget 2018: What young India needs from Modi Sarkar

Rediff.com31 Jan 2018

Education, jobs, health and more: Experts share their wishlist.

PM discusses Covid vaccine strategy with CMs

PM discusses Covid vaccine strategy with CMs

Rediff.com24 Nov 2020

The modalities of COVID-19 vaccine delivery, distribution and administration were discussed during the meeting.

India readies for massive testing exercise after lockdown

India readies for massive testing exercise after lockdown

Rediff.com28 Mar 2020

The ICMR is working on a war footing to develop the testing ecosystem -- especially for the screening blood tests. NIV, Pune, is in the process of validating antibody-based screening kits.

How tech alumni plan to raise 21,000 crore to fight COVID-19

How tech alumni plan to raise 21,000 crore to fight COVID-19

Rediff.com2 Jul 2020

Over 5 million alumni from the Indian Institutes of Technology, Mumbai University and Institute of Chemical Technology, Mumbai, plan to raise Rs 21,000 crore to start the world's largest infection testing lab in Mumbai.

Covid: Big 3rd wave unlikely in India, say experts

Covid: Big 3rd wave unlikely in India, say experts

Rediff.com23 Nov 2021

Is the worst of the Covid crisis behind India? As cases dip three weeks after Diwali, the answer is a possible yes, say several experts, attributing the downslide to a large section of the population already exposed to the virus during the second wave and a stepped up vaccination campaign.

Rs 93,847 crore allocated for education in interim budget

Rs 93,847 crore allocated for education in interim budget

Rediff.com1 Feb 2019

While Rs 37,461.01 crore has been allocated for higher education, Rs 56,386.63 crore has been earmarked for school education.

Ghaziabad man becomes 30th coronavirus case in India

Ghaziabad man becomes 30th coronavirus case in India

Rediff.com5 Mar 2020

The Paytm employee, who tested positive for the contagious disease with flu like symptoms on Wednesday, came in touch with 91 people in Gurgaon, an official said, citing his counterpart in the suburban town.

She has cracked the code to help smokers quit

She has cracked the code to help smokers quit

Rediff.com6 Dec 2017

'Running a start-up is hard.' 'We almost always will have obstacles.' 'There are two ways to tackle it.' 'We can either take them head on or let them hold you back.'

Parliament gives nod to Mental Healthcare Bill

Parliament gives nod to Mental Healthcare Bill

Rediff.com27 Mar 2017

The bill seeks to ensure health-care, treatment and rehabilitation of persons with mental illness "in a manner that does not intrude on their rights and dignity."